{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:11Z","timestamp":1787008631198,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100004851","name":"New York City Department of Health and Mental Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2016,1,1]]},"DOI":"10.1093\/cid\/civ766","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T20:44:01Z","timestamp":1441313041000},"page":"53-59","source":"Crossref","is-referenced-by-count":32,"title":["Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics"],"prefix":"10.1093","volume":"62","author":[{"given":"Natalie L.","family":"Stennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N.","family":"Burzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Macaraig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"key":"2015121503080059000_62.1.53.1","first-page":"1","article-title":"Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2015121503080059000_62.1.53.2","unstructured":"The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015. World Health Organization. Available at: http:\/\/www.who.int\/tb\/post2015_TBstrategy.pdf?ua=1 . Accessed 16 December 2014."},{"key":"2015121503080059000_62.1.53.3","volume-title":"Ending neglect: the elimination of tuberculosis in the United States","author":"Institute of Medicine","year":"2000"},{"key":"2015121503080059000_62.1.53.4","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"issue":"RR06","key":"2015121503080059000_62.1.53.5","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2015121503080059000_62.1.53.6","first-page":"10","article-title":"Aggregate reports for tuberculosis program evaluation","volume-title":"Tuberculosis controllers","author":"Chorba","year":"2014"},{"key":"2015121503080059000_62.1.53.7","unstructured":"United States Census Bureau. 2010 Census Summary. Generated using American Fact Finder. Available at: http:\/\/www.census.gov\/quickfacts\/table\/POP010210\/3651000,00 . Accessed 11 December 2014."},{"key":"2015121503080059000_62.1.53.8","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu047","article-title":"Estimated prevalence of tuberculosis infection among a New York City clinic population using interferon-gamma release assays","author":"Stennis","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"2015121503080059000_62.1.53.9","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","article-title":"Adherence to treatment of latent tuberculosis infection in a clinical population in New York City","volume":"14","author":"Li","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2015121503080059000_62.1.53.10","unstructured":"National Association of County & City Health Officials. Program Details, Telephone Nurse Monitoring Program (TNMP) 2008. Available at: http:\/\/www.naccho.org\/topics\/modelpractices\/database\/practice.cfm?PracticeID=480 . Accessed 11 December 2014."},{"key":"2015121503080059000_62.1.53.11","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2015121503080059000_62.1.53.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"2015121503080059000_62.1.53.13","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2015121503080059000_62.1.53.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200303-390OC"},{"key":"2015121503080059000_62.1.53.15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5588\/ijtld.12.0697","article-title":"Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada","volume":"17","author":"Colson","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2015121503080059000_62.1.53.16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/1471-2458-11-916","article-title":"Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia","volume":"12","author":"Mindachew","year":"2011","journal-title":"BMC Public Health"},{"key":"2015121503080059000_62.1.53.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087166"},{"key":"2015121503080059000_62.1.53.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301702"},{"key":"2015121503080059000_62.1.53.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302253280825"},{"key":"2015121503080059000_62.1.53.20","first-page":"779","article-title":"Videophone utilization as an alternative to directly observed therapy for tuberculosis","volume":"14","author":"Krueger","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2015121503080059000_62.1.53.21","first-page":"12","article-title":"CDC Tuberculosis Trials Consortium (TBTC) study 33 (iAdhere)","volume":"4","author":"Borisov","year":"2014","journal-title":"TB Notes"},{"key":"2015121503080059000_62.1.53.22","unstructured":"Treatment Action Group. Rifapentine. 2013. Available at: http:\/\/www.treatmentactiongroup.org\/tb\/drugs-advocacy\/rifapentine . Accessed 16 September 2014."},{"key":"2015121503080059000_62.1.53.23","unstructured":"Centers for Disease Control and Prevention. Application Guidance for FY2010 [CDC-RFA-PS10-1005]. Tuberculosis Elimination and Laboratory Cooperative Agreements. Atlanta: CDC, 2009."},{"key":"2015121503080059000_62.1.53.24","article-title":"Advancing toward elimination","volume-title":"Ending neglect: the elimination of tuberculosis in the United States","author":"Geiter","year":"2000"},{"key":"2015121503080059000_62.1.53.25","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0423"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/62\/1\/53\/16787412\/civ766.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:15:48Z","timestamp":1503566148000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,15]]},"published-print":{"date-parts":[[2016,1,1]]}},"alternative-id":["10.1093\/cid\/civ766"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ766","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}